PATENT CLAIM ANALYSIS

Application Number: 16241215
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "301000"]

Abstract:
Described herein are novel compounds and methods for the treatment and/or prevention of cerebral amyloidoses such as Alzheimer's disease (AD) and/or cerebral amyloid angiopathy (CAA).

Claim (Index 14):
A method for treating Alzheimer's disease and/or cerebral amyloid angiopathy in a patient at risk for developing or diagnosed with the same, the method comprising administering to the patient an effective amount of the compound of  claim 1 .

Metadata:
- Claim Count in Document: 13.0
- Percentile: 99.0
- Lexical Diversity: 1.14815
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16004723', '15377437', '13390856', '14009654', '15509984']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7696930933286262
- 35 USC 102 Novelty (BERT): 0.5217427727804966
- Combined Prediction Score: 0.7448980612738133
- Mean Citation Score: 291.08354799999995
- Max Citation Score: 346.7746
- Similarity Product: 344.1492377606273

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test